piperazine has been researched along with Diabetes Mellitus, Type 2 in 4 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taha, M | 1 |
| Irshad, M | 1 |
| Imran, S | 1 |
| Chigurupati, S | 1 |
| Selvaraj, M | 1 |
| Rahim, F | 1 |
| Ismail, NH | 1 |
| Nawaz, F | 1 |
| Khan, KM | 1 |
| Kushwaha, RN | 1 |
| Srivastava, R | 1 |
| Mishra, A | 1 |
| Rawat, AK | 1 |
| Srivastava, AK | 1 |
| Haq, W | 1 |
| Katti, SB | 1 |
| Sharma, R | 1 |
| Sun, H | 1 |
| Piotrowski, DW | 1 |
| Ryder, TF | 1 |
| Doran, SD | 1 |
| Dai, H | 1 |
| Prakash, C | 1 |
| Yoshida, T | 1 |
| Sakashita, H | 1 |
| Akahoshi, F | 1 |
| Hayashi, Y | 1 |
4 other studies available for piperazine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study.
Topics: alpha-Amylases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Huma | 2017 |
Design, synthesis, biological screening, and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV I | 2015 |
Metabolism, excretion, and pharmacokinetics of ((3,3-difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, a dipeptidyl peptidase inhibitor, in rat, dog and human.
Topics: Amides; Animals; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Di | 2012 |
[(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.
Topics: Animals; Chemistry, Pharmaceutical; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; D | 2007 |